Fundação de Medicina Tropical Dr Heitor Vieira Dourado Trials

Fundação de Medicina Tropical Dr Heitor Vieira Dourado	Welcome, Profile Billing Logout

Fundação de Medicina Tropical Dr Heitor Vieira Dourado

Welcome, Profile Billing Logout

4 Trials

7 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Lacerda, Marcus VG

COVACMANAUS, NCT04789356: Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity

Active, not recruiting

6233

RoW

Adsorbed SARS-CoV-2 (inactivated) vaccine, CoronaVac

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Butantan Institute

Covid19

07/21

03/22

CuraVivax, NCT03208907: DHA-PQP vs Chloroquine and Primaquine for Radical Cure of Vivax Malaria in Brazil

Completed

419

RoW

CQ coadministered with PQ, Standard treatment with potential synergy, DHA-PQP coadministered with PQ, Experimental treatment with potential synergy, CQ and PQ starting on Day 42, Standard treatment with no potential synergy, DHA-PQP and PQ starting on Day 42, Experimental treatment with no potential synergy

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Ministry of Health, Brazil, Oswaldo Cruz Foundation

Malaria, Vivax, Therapeutics

07/21

NCT04650399: A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents

Completed

750

RoW

Active, Placebo

Butantan Institute, Valneva Austria GmbH

Chikungunya

02/23

02/24

DOVETAIL, NCT06497465: Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Not yet recruiting

150

RoW

Dolutegravir 50mg Tab, TIVICAY 50 mg, TIVICAY PD, Dolutegravir/Lamivudine 50 MG-300mg Oral Tablet [DOVATO], Dolutegravir plus Tenofovir disoproxil fumarate (TDF)/ lamivudine (3TC)

Johns Hopkins University, ViiV Healthcare

Tuberculosis, HIV

01/28

01/29

NCT03529396: Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients

Completed

106

RoW

Chloroquine, Primaquine

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Oswaldo Cruz Foundation, Conselho Nacional de Desenvolvimento Científico e Tecnológico

Vivax Malaria, G6PD Deficiency

12/22

07/23

COVACManaus2, NCT05289206: Immune Response of an Interchangeable Booster Vaccine Against COVID-19 Among Individuals With Risk Factors for Severity

Active, not recruiting

N/A

4446

RoW

Vaccine - ChAdOx1-S/nCoV-19 [recombinant]

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM), XP Investimentos, Universidade do Estado do Amazonas (UEA), Instituto Leonidas e Maria Deane (ILMD)/ FIOCRUZ-AM

Comorbidities and Coexisting Conditions, Healthy

03/22

05/22

Trust, NCT05096702: Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil

Active, not recruiting

N/A

16000

RoW

Tafenoquine, Kozenis, Primaquine

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Centro de Pesquisa em Medicina Tropical, Medicines for Malaria Venture, Ministry of Health, Brazil, Secretária Municipal de Saúde de Manaus, Secretária Estadual de Saúde do Amazonas

Malaria, Vivax, G6PD Deficiency

08/22

09/23

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Lacerda, Marcus VG

COVACMANAUS, NCT04789356: Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity

Active, not recruiting

6233

RoW

Adsorbed SARS-CoV-2 (inactivated) vaccine, CoronaVac

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Butantan Institute

Covid19

07/21

03/22

CuraVivax, NCT03208907: DHA-PQP vs Chloroquine and Primaquine for Radical Cure of Vivax Malaria in Brazil

Completed

419

RoW

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Ministry of Health, Brazil, Oswaldo Cruz Foundation

Malaria, Vivax, Therapeutics

07/21

NCT04650399: A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents

Completed

750

RoW

Active, Placebo

Butantan Institute, Valneva Austria GmbH

Chikungunya

02/23

02/24

DOVETAIL, NCT06497465: Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Not yet recruiting

150

RoW

Dolutegravir 50mg Tab, TIVICAY 50 mg, TIVICAY PD, Dolutegravir/Lamivudine 50 MG-300mg Oral Tablet [DOVATO], Dolutegravir plus Tenofovir disoproxil fumarate (TDF)/ lamivudine (3TC)

Johns Hopkins University, ViiV Healthcare

Tuberculosis, HIV

01/28

01/29

NCT03529396: Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients

Completed

106

RoW

Chloroquine, Primaquine

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Oswaldo Cruz Foundation, Conselho Nacional de Desenvolvimento Científico e Tecnológico

Vivax Malaria, G6PD Deficiency

12/22

07/23

COVACManaus2, NCT05289206: Immune Response of an Interchangeable Booster Vaccine Against COVID-19 Among Individuals With Risk Factors for Severity

Active, not recruiting

N/A

4446

RoW

Vaccine - ChAdOx1-S/nCoV-19 [recombinant]

Comorbidities and Coexisting Conditions, Healthy

03/22

05/22

Trust, NCT05096702: Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil

Active, not recruiting

N/A

16000

RoW

Tafenoquine, Kozenis, Primaquine

Malaria, Vivax, G6PD Deficiency

08/22

09/23

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites